India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Can the sun cause skin cancer? The number of people suffering from skin cancer is increasing. Skin cancer is likely to occur especially when the body is directly exposed to the sun's radiation. People who spend a lot of time in the sun, work in the sun, have excessive body fat, have sensitive skin, and have a family history of skin cancer are likely to develop skin cancer. How does the sun cause skin cancer? The ultraviolet rays from the sun are very harmful. When UVA, UVB radiation comes into direct contact with the body, it affects the skin and increases the risk of cancer. Most people over the age of 65 are more likely to develop skin cancer. Because at this age the immunity is weak. Types of skin cancer There are three types of skin cancer, basal cell carcinoma, squamous cell carcinoma and melanoma. Basal Cell Carcinoma: Prolonged exposure to direct sunlight can cause this type of cancer. Such as face, ears, cheeks, neck and hands appear and gradually increase. It can be cured ...